Author:
Alimohammadian Mohammad Hossein,Khamesipour Ali,Darabi Haiedeh,Firooz Alireza,Malekzadeh Shirin,Bahonar Ahmad,Dowlati Yahya,Modabber Farrokh
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference22 articles.
1. First generation leishmaniasis vaccines in clinical development: moving, but what next;Modabber;Curr. Opin. Anti-infective Investig. Drugs,2000
2. Dowlati Y, Ehsasi S, Shidani B, Bahar K. Stepwise safety trial of a killed Leishmania vaccine in Iran. In: Dowlati Y, Modabber F, editors. Clinics in dermatology, vol. 14. Amsterdam: Elsevier; 1996. p. 497–502.
3. Bahar K, Dowlati Y, Shidani B, Alimohammadian MH, Khamesipour A, Ehsasi S, et al. Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers. In: Dowlati Y, Modabber F, editors. Clinics in dermatology 1996, vol. 14. Amsterdam: Elsevier; 1996. p. 489–95.
4. Randomised vaccine trial of a single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran;Sharifi;Lancet,1998
5. A randomized, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran;Momeni;Vaccine,1999
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献